Home > Biochemistry News > Biotechnology News > Lin Shuhai's research group co-published a research paper in the "Proceedings of the National Academy of Sciences" to identify metabolites that regulate the level of new crown antibodies

Lin Shuhai's research group co-published a research paper in the "Proceedings of the National Academy of Sciences" to identify metabolites that regulate the level of new crown antibodies

  • Last Update: 2022-08-20
  • Source: Internet
  • Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Since the outbreak of COVID-19, Lin Shuhai's research group has carried out a series of metabolism-related studies, and has cooperated to identify metabolic markers in different stages of COVID-19 (National Science Review 2020), as well as the abnormal analysis of milk proteins and metabolites in maternal patients with COVID-19.


On August 9, Lin Shuhai's group published a research paper entitled Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients in PNAS


In this research work, Lin Shuhai's research group and the cooperative team collected the plasma samples of recovered subjects with COVID-19 carrying antibodies, recovered subjects with COVID-19 but the antibodies subsided, and healthy volunteers, and carried out targeted metabolomics and quantification of inflammatory factors.


Since glycylproline can be catalyzed by DPP4, the use of sitagliptin (DPP4 inhibitor) can reduce the level of glycylproline


Therefore, the researchers used a single dose of SARS-CoV-2 RBD protein fragment intraperitoneally injected into BALB/c female mice and detected immune cell subsets (germinal center B cells (GC B cells), follicular helper T cells (Tfh) and plasma cells to elucidate that glycylproline can modulate antibody immune responses



This study shows that there are significant differences in plasma glycylproline concentrations in subjects with different levels of COVID-19 antibodies, and the level of neutralizing antibodies in mammals vaccinated against COVID-19 is indeed regulated by glycylproline, suggesting that glycylproline Aminoacylproline can be used to identify or differentiate subjects vaccinated against COVID-19 with different antibody levels


The School of Life Sciences of Xiamen University is the first completion unit


Original link:Lin Shuhai Research Group)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Contact Us

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.